Regentis Biomaterials (RGNT) Total Current Liabilities (2024 - 2025)
Regentis Biomaterials' (RGNT) quarterly Total Current Liabilities came in at $2.9 million in Q4 2025, down 55.7% year-on-year from $6.5 million in Q4 2024, and down 55.7% on a QoQ basis from $6.5 million in Q4 2024.
Regentis Biomaterials (RGNT) Total Current Liabilities (2024 - 2025) Analysis & Trends
Regentis Biomaterials (RGNT) has 2 years of Total Current Liabilities data on file, last reported at $2.9 million in Q4 2025.
- On a quarterly basis, Total Current Liabilities fell 55.7% year-over-year to $2.9 million in Q4 2025; TTM through Dec 2025 was $2.9 million, a 55.7% decrease from a year earlier, with the FY2025 full-year figure at $2.9 million, down 55.7% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $2.9 million, down from $6.5 million in the prior quarter.
- Over the last five years, Total Current Liabilities for RGNT reached as high as $6.5 million in Q4 2024 and fell as low as $2.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 3.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 8.51 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.54 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.35 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 3.35 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.91 Bn |
| 10 | Regentis Biomaterials | 1.10 Mn | -6.28 Mn | - | 2.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.87 Mn |
| Dec 31, 2024 | 6.49 Mn |